UBS Group’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $805M | Sell |
|
|||||
|
2025
Q1 | $783M | Buy |
|
|||||
|
2024
Q4 | $622M | Buy |
|
|||||
|
2024
Q3 | $403M | Buy |
|
|||||
|
2024
Q2 | $327M | Buy |
|
|||||
|
2024
Q1 | $355M | Buy |
|
|||||
|
2023
Q4 | $346M | Buy |
|
|||||
|
2023
Q3 | $306M | Buy |
|
|||||
|
2023
Q2 | $261M | Buy |
|
|||||
|
2023
Q1 | $244M | Sell |
|
|||||
|
2022
Q4 | $275M | Buy |
|
|||||
|
2022
Q3 | $204M | Sell |
|
|||||
|
2022
Q2 | $252M | Sell |
|
|||||
|
2022
Q1 | $300M | Buy |
|
|||||
|
2021
Q4 | $259M | Sell |
|
|||||
|
2021
Q3 | $249M | Sell |
|
|||||
|
2021
Q2 | $290M | Sell |
|
|||||
|
2021
Q1 | $305M | Sell |
|
|||||
|
2020
Q4 | $286M | Buy |
|
|||||
|
2020
Q3 | $243M | Buy |
|
|||||
|
2020
Q2 | $203M | Sell |
|
|||||
|
2020
Q1 | $218M | Sell |
|
|||||
|
2019
Q4 | $281M | Sell |
|
|||||
|
2019
Q3 | $329M | Sell |
|
|||||
|
2019
Q2 | $308M | Sell |
|
|||||
|
2019
Q1 | $272M | Buy |
|
|||||
|
2018
Q4 | $308M | Buy |
|
|||||
|
2018
Q3 | $245M | Buy |
|
|||||
|
2018
Q2 | $227M | Sell |
|
|||||
|
2018
Q1 | $264M | Sell |
|
|||||
|
2017
Q4 | $260M | Buy |
|
|||||
|
2017
Q3 | $209M | Buy |
|
|||||
|
2017
Q2 | $183M | Buy |
|
|||||
|
2017
Q1 | $145M | Buy |
|
|||||
|
2016
Q4 | $115M | Buy |
|
|||||
|
2016
Q3 | $104M | Sell |
|
|||||
|
2016
Q2 | $97.5M | Sell |
|
|||||
|
2016
Q1 | $105M | Sell |
|
|||||
|
2015
Q4 | $102M | Buy |
|
|||||
|
2015
Q3 | $95.1M | Sell |
|
|||||
|
2015
Q2 | $109M | Sell |
|
|||||
|
2015
Q1 | $125M | Sell |
|
|||||
|
2014
Q4 | $122M | Buy |
|